Global Genetic Toxicology Market Growth (Status and Outlook) 2025-2031

The global Genetic Toxicology market size is predicted to grow from US$ 241760 million in 2025 to US$ 341250 million in 2031; it is expected to grow at a CAGR of 5.9% from 2025 to 2031.

Genetic toxicology is a branch of toxicology that focuses on the study of the genetic damage or mutations caused by various physical, chemical, and biological agents. These agents, often referred to as genotoxic agents, have the potential to alter the genetic material within cells, including DNA, which can lead to mutations or other genetic changes. Genetic toxicology is an important field for assessing the safety of various substances, including pharmaceuticals, chemicals, environmental pollutants, and radiation.

Increased Regulatory Scrutiny: Regulatory agencies worldwide continue to emphasize the importance of genetic toxicology testing in assessing the safety of pharmaceuticals, chemicals, and various products. The demand for such testing is likely to remain high as regulations evolve.

Advancements in Testing Methods: The field of genetic toxicology has seen advances in testing methods and technologies. This includes the development of more sensitive and specific assays, high-throughput screening, and the use of 3D cell culture models, which enhance the accuracy and efficiency of testing.

Growing Demand for In Vitro Testing: There"s a shift toward in vitro (test tube or cell-based) genetic toxicology testing, which can reduce the need for animal testing and offer faster and more cost-effective results. This is in line with broader trends in reducing animal testing.

Assessment of Genomic Data: With the increasing availability of genomic data, there"s a trend toward integrating genomics and bioinformatics into genetic toxicology studies. This allows for a deeper understanding of mechanisms and the identification of genetic biomarkers for toxicity.

LPI (LP Information)' newest research report, the “Genetic Toxicology Industry Forecast” looks at past sales and reviews total world Genetic Toxicology sales in 2024, providing a comprehensive analysis by region and market sector of projected Genetic Toxicology sales for 2025 through 2031. With Genetic Toxicology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genetic Toxicology industry.

This Insight Report provides a comprehensive analysis of the global Genetic Toxicology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Genetic Toxicology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Genetic Toxicology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genetic Toxicology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genetic Toxicology.

This report presents a comprehensive overview, market shares, and growth opportunities of Genetic Toxicology market by product type, application, key players and key regions and countries.

Segmentation by Type:
Genotoxicity Screening Assays
GLP Standard Genotoxicity Assays

Segmentation by Application:
Mini Ames/Ames
Gene Mutation
In Vitro Micronucleus
Chromosome Aberration
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Frontage Laboratories
Accelera
Charles River
Pharmaron
Labcorp
Syngene
Vivotecnia
Technics
Aurigene Pharmaceutical Services
ERBC Group
NextGen
Cardinal Health
Toxys
Abbott Toxicology
Evotec
EPL

Please note: The report will take approximately 2 business days to prepare and deliver.